À propos
Chris Denison is a Partner and Patent Attorney in the Life Sciences department at Mewburn Ellis LLP, specialising in prosecution, opposition and appeal work at the European Patent Office and providing litigation support in the biotech and biopharmaceutical sectors. He has extensive experience in large portfolio management and works with international clients; he joined Mewburn Ellis in 1996, qualified as a Chartered Patent Attorney in 1999, as a European Patent Attorney in 2000, and became a partner in 2002.
Domaines d’expertise
Intellectual PropertyPatent ProsecutionPatent LitigationLife SciencesBiotechnology
Bureau
Expertise
Antibodies (targeted anti-cancer antibodies)miRNANovel nucleotidesFunctional foods (niche interest)BiopharmaceuticalsLarge portfolio management
Formation
- Degree in Neuroscience, University of Cambridge
Inscriptions au barreau
- Chartered Patent Attorney (qualified 1999)
- European Patent Attorney (qualified 2000)